Inhibition of type a GABA receptors by L-type calcium channel blockers

Neuroscience

Volumn 124, Issue 1, 2004, Pages 195-206

  Das, P ^a   Bell Horner, C L ^a   Huang, R Q ^a   Raut, A ^a   Gonzales, E B ^a   Chen, Z L ^a   Covey, D F ^b   Dillon, G H ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Cl channel; Dihydropyridine; L type Ca++ channel; Recombinant receptor

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIHYDROPYRIDINE DERIVATIVE; FLUMAZENIL; NIFEDIPINE; NITRENDIPINE; PICROTOXIN; VERAPAMIL;

ARTICLE; CHANNEL GATING; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0442307911     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.12.005     Document Type: Article

References (49)

1. Bergey G.K. Future antiepileptic drug development. Neurology. 55:(Supp l):2000;S47-S53.
2. A receptors. Mol Brain Res. 76:2000;47-55.
3. Bernard C., Cossart R., Hirsch J.C., Esclapez M., Ben-Ari Y. What is GABAergic inhibition? How is it modified in epilepsy? Epilepsia. 41:(Suppl S95.6):2000;S90-S95.
4. A receptors suggest differential targeting of receptor subtypes. J Neurosci. 19:1999;2960-2973.
5. Canney D.J., Holland K.D., Levine L.A., McKeon A.C., Ferrendelli J.A., Covey D.F. Synthesis and structure-activity studies of alkyl-substituted γ-butyrolactones and γ-thiobutyrolactones Ligands for the picrotoxin receptor . J Med Chem. 34:1991;1460-1467.
6. Chen C., Okayama H. High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 7:1987;2745-2750.
7. Chesnoy-Marchais D., Cathala L. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons. Eur J Neurosci. 13:2001;2195-2204.
8. Coulter D.A. Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties. Int Rev Neurobiol. 45:2001;237-252.
9. Cunningham M.G., McKay R.D.G. A hypothermic miniaturized stereotaxic instrument for surgery in newborn rats. J Neurosci Methods. 47:1993;105-114.
10. A receptor subtype. Br J Pharmacol. 115:1995;539-545.
11. A receptors and decreases single-channel open probability. J Pharmacol Exp Ther. 272:1995;597-603.
12. Dolin S.J., Patch T.L., Rabbini M., Taberner P.V., Little H.J. Differential interactions between benzodiazepines and the dihydropyridines, nitrendipine and BAY K 8644. Neuropharmacology. 30:1991;217-224.
13. Donnelly-Roberts D.L., Arneric S.P., Sullivan J.P. Functional modulation of human "ganglionic-like" neuronal nicotinic acetylcholine receptors (nAchRs) by L-type calcium channel antagonists. Biochem Biophys Res Comm. 213:1995;657-662.
14. Eisenman L.N., He Y., Fields C., Zorumski C.F., Mennerick S. Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current. J Physiol. 550:2003;679-691.
15. Franks N.P., Lieb W.R. Molecular and cellular mechanisms of anesthesia. Nature. 367:1994;607-614.
16. A receptor subtypes during postnatal developmental An immunohistochemical study . J Neurosci. 14:1994;5302-5324.
17. Gatch M.B., Wallis C.J., Lal H. Effects of calcium channel blockers on pentylenetetrazole drug discrimination in rats. Alcohol. 23:2001;141-147.
18. Genkova-Papazova M., Petkova B.S., Bakarova M.L., Boyanova E., Stoytcheva D.S. Effects of flunarizine and nitrendipine on electroconvulsive shock and clonidine induced amnesia. Pharmacol Biochem Behav. 56:1997;583-587.
19. A receptors An allosteric, state-dependent mechanism determined by the γ subunit . J Physiol. 506:1998;609-625.
20. A channel that abolish block by picrotoxin. Recep Chan. 3:1995;13-20.
21. A receptor subunits in a human kidney cell line. Neurosci Lett. 153:1993;206-209.
22. 2+ channels. Mol Pharmacol. 50:1996;1284-1294.
23. Hawkinson J.E., Drewe J.A., Kimbrough C.L., Chen J.-S., Hogenkamp D.J., Lan N.C., Gee K.W., Shong K.-Z., Whittemore E.R., Woodward R.M. 3α-hydroxy-3β-trifluoromethyl-5α-pregnan-20-1 (Co 2-1970) A partial agonist at the neuroactive steroid site of the γ-aminobutyric acid receptor . Mol Pharmacol. 49:1996;897-906.
24. 2+ transients in rat and canine cardiomyocytes. J Mol Cell Cardiol. 29:1997;1037-1043.
25. a channel subtypes . Mol Neurobiol. 18:1998;35-86.
26. A receptors. Mol Pharmacol. 53:1998;870-877.
27. A receptors Discrete binding sites underlie subtype specificity . Nat Neurosci. 6:2003;362-368.
28. A receptors. Neuropharmacology. 39:2000;2533-2542.
29. A receptors Mechanism and site of action . J Pharmacol Exp Ther. 298:2001;986-995.
30. Hung R.Q., Dillon G.H. Effects of extracellular pH or GABA-activated current in rat recombinant receptors and thin hypothalamic slices. J Neurophysiol. 82:1999;1233-1243.
31. Ikegaya Y., Nishiyama N., Matsuki N. L-type calcium blocker inhibits mossy fiber sprouting and cognitive deficits following pilocarpine seizures in immature mice. Neuroscience. 98:2000;647-659.
32. A receptors. Neuropharmacology. 35:1996;1289-1298.
33. Magnon M., Gallix P., Cavero I. Intervessal (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers Variable, vessel-dependent indexes . J Pharmacol Exp Ther. 275:1995;1157-1166.
34. Matsumoto R.R., Truong D.D., Nguyen K.D., Dang A.T., Hoang T.T., Vo P.Q., Sandroni P. Involvement of GABA(A) receptors in myoclonus. Mov Disord. 15:(Suppl 1):2000;47-52.
35. McKernan R.M., Wafford K., Quirk K.L., Hadingham E.A., Harley C.I., Whiting P.I. The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent on the type of γ subunit present. J Recept Signal Transduct Res. 15:1995;173-183.
36. Murai Y., Uneyama H., Ishibashi H., Takahama K., Akaike N. Preferential inhibition of L-type and N-type calcium channels in the rat hippocampal neurons by cilnidipine. Brain Res. 854:2000;6-10.
37. Newland C.F., Cull-Candy S.G. On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. J Physiol. 447:1992;191-213.
38. A receptors. Trends Pharmacol Sci. 18:1997;425-429.
39. Skeen G.A., Twyman R.E., White H.S. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol Pharmacol. 44:1993;443-450.
40. Skeen G.A., White H.S., Twyman R.E. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor associated ion channel. J Pharmacol Exp Ther. 271:1994;30-38.
41. A receptors are differentially sensitive to zinc Dependence on subunit composition . Br J Pharmacol. 103:1991;1837-1839.
42. 2+ channels. Trends Pharmacol Sci. 19:1998;108-115.
43. Testa M.A., Turner R.R., Sominson D.C., Krafcik M.B., Calvo C., Luque-Otero M. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine patients in Spain. J Hypertens. 16:1998;1839-1847.
44. Van Renterghem C., Bilbe G., Moss S., Smart T.G., Constanti A., Brown D.A., Barnard E.A. GABA receptors induced in Xenopus oocytes by chick brain mRNA Evaluation of tbps as a use-dependent blocker . Mol Brain Res. 2:1987;21-31.
45. 2+ channel α1 subunits. J Biol Chem. 276:2001;12730-12735.
46. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40:(Suppl 5):1999;S2-S10.
47. A receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol. 63:2003;2-8.
48. Yoon K.W., Covey D.F., Rothman S.M. Multiple mechanisms of picrotoxin block of GABA-mediated currents in rat hippocampal neurons. J Physiol. 464:1993;423-439.
49. 2+ channel interaction . Trends Pharmacol Sci. 11:1990;38-44.